CCM
Income statement / Annual
Last year (2023), Concord Medical Services Holdings Limited's total revenue was $537.40 M,
an increase of 13.84% from the previous year.
In 2023, Concord Medical Services Holdings Limited's net income was -$297.66 M.
See Concord Medical Services Holdings Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$537.40 M |
$472.09 M |
$485.63 M |
$223.01 M |
$198.36 M |
$190.90 M |
$330.98 M |
$455.04 M |
$616.49 M |
$606.88 M |
| Cost of Revenue |
$614.01 M
|
$624.49 M
|
$542.53 M
|
$209.93 M
|
$214.19 M
|
$171.14 M
|
$232.98 M
|
$286.54 M
|
$353.34 M
|
$274.56 M
|
| Gross Profit |
-$76.61 M
|
-$152.41 M
|
-$56.90 M
|
$13.08 M
|
-$15.83 M
|
$19.76 M
|
$98.00 M
|
$168.50 M
|
$263.15 M
|
$332.32 M
|
| Gross Profit Ratio |
-0.14
|
-0.32
|
-0.12
|
0.06
|
-0.08
|
0.1
|
0.3
|
0.37
|
0.43
|
0.55
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$308.71 M
|
$311.16 M
|
$347.75 M
|
$294.82 M
|
$315.13 M
|
$291.85 M
|
$237.65 M
|
$205.91 M
|
$132.95 M
|
$53.58 M
|
| Selling & Marketing Expenses |
$56.30 M
|
$61.48 M
|
$53.68 M
|
$25.76 M
|
$30.24 M
|
$21.72 M
|
$43.61 M
|
$70.09 M
|
$112.82 M
|
$95.10 M
|
| Selling, General & Administrative Expenses |
$386.38 M
|
$372.64 M
|
$401.42 M
|
$320.58 M
|
$345.38 M
|
$313.57 M
|
$281.25 M
|
$276.00 M
|
$245.77 M
|
$148.67 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$8.50 M
|
$76.09 M
|
$5.43 M
|
$28.60 M
|
$61.12 M
|
$23.13 M
|
$0.00
|
| Operating Expenses |
$386.38 M
|
$372.64 M
|
$401.42 M
|
$329.08 M
|
$421.46 M
|
$319.01 M
|
$309.85 M
|
$337.13 M
|
$268.89 M
|
$148.67 M
|
| Cost And Expenses |
$1.00 B
|
$997.13 M
|
$943.95 M
|
$539.01 M
|
$635.66 M
|
$490.14 M
|
$542.83 M
|
$623.67 M
|
$622.23 M
|
$423.23 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$118.83 M
|
$123.19 M
|
$94.46 M
|
$70.79 M
|
$56.35 M
|
$45.02 M
|
$89.45 M
|
$127.81 M
|
$157.25 M
|
$198.07 M
|
| EBITDA |
-$344.16 M |
-$401.86 M |
-$363.86 M |
-$236.72 M |
-$304.85 M |
-$248.79 M |
-$93.80 M |
$20.31 M |
$174.63 M |
$381.72 M |
| EBITDA Ratio |
-0.49
|
-1.23
|
-0.68
|
-0.93
|
-1.33
|
-1.11
|
-0.22
|
0.15
|
0.11
|
0.36
|
| Operating Income Ratio |
-0.86
|
-1.11
|
-0.94
|
-1.38
|
-2.2
|
-1.57
|
-0.64
|
-0.37
|
-0.01
|
0.3
|
| Total Other Income/Expenses Net |
-$92.61 M
|
-$314.85 M
|
-$70.92 M
|
-$125.65 M
|
$46.22 M
|
$74.00 M
|
-$42.04 M
|
-$35.97 M
|
$489,000.00
|
-$8.00 M
|
| Income Before Tax |
-$555.59 M
|
-$839.90 M
|
-$529.24 M
|
-$441.65 M
|
-$391.08 M
|
-$225.25 M
|
-$253.90 M
|
-$204.60 M
|
-$5.25 M
|
$175.65 M
|
| Income Before Tax Ratio |
-1.03
|
-1.78
|
-1.09
|
-1.98
|
-1.97
|
-1.18
|
-0.77
|
-0.45
|
-0.01
|
0.29
|
| Income Tax Expense |
$24.57 M
|
$70.91 M
|
$6.57 M
|
$37.62 M
|
$38.99 M
|
$34.05 M
|
$31.79 M
|
$60.49 M
|
$74.03 M
|
$80.85 M
|
| Net Income |
-$297.66 M
|
-$489.66 M
|
-$271.43 M
|
-$309.99 M
|
-$307.05 M
|
-$234.88 M
|
-$284.32 M
|
-$261.87 M
|
-$78.30 M
|
$124.71 M
|
| Net Income Ratio |
-0.55
|
-1.04
|
-1.69
|
-3
|
-2.79
|
-1.88
|
-0.86
|
-0.58
|
-0.13
|
0.16
|
| EPS |
-2.27 |
-3.74 |
-6.26 |
-7.76 |
-4.24 |
-2.76 |
-2.19 |
-2 |
-0.58 |
0.73 |
| EPS Diluted |
-2.27 |
-3.74 |
-2.07 |
-2.37 |
-2.36 |
-1.81 |
-2.19 |
-2 |
-0.58 |
0.92 |
| Weighted Average Shares Out |
$131.05 M
|
$131.05 M
|
$43.35 M
|
$39.93 M
|
$72.38 M
|
$85.07 M
|
$130.09 M
|
$130.63 M
|
$134.55 M
|
$170.47 M
|
| Weighted Average Shares Out Diluted |
$131.05 M
|
$131.05 M
|
$131.05 M
|
$131.05 M
|
$130.24 M
|
$130.10 M
|
$130.09 M
|
$130.63 M
|
$134.55 M
|
$135.18 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
